首页 >
法规速递
-
Page: List of medicines under additional monitoring-2025/1/29
2025-02-05查看详情 > -
Document: Minutes - PDCO minutes of the 12-15 November 2024 meeting-2025/3/5
2025-03-06查看详情 > -
国家药监局关于发布《化妆品安全风险监测与评价管理办法》的公告（2025年第37号）-2025/4/9
2025-04-11查看详情 > -
Document: Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products-2025/5
2025-05-20查看详情 > -
Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment-2025/6/26
2025-06-27查看详情 > -
Page: Rivaroxaban product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Document: EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 2: Format for the electronic submission of veterinary medicinal product information-2025/9/16
2025-09-17查看详情 > -
Document: Medicinal products for human use: monthly figures - September 2025-2025/10/22
2025-10-23查看详情 > -
Document: European Medicines Agency’s data protection notice for PMS user acceptance stakeholder involvement-2025/11/25
2025-11-26查看详情 > -
国家药监局关于批准注册305个医疗器械产品的公告（2025年11月）（2025年第121号）-2025/12/17
2025-12-18查看详情 >
